Cohen; Rakefet

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cohen; Rakefet.The latest application filed is for "process for manufacturing glatiramer acetate product".

Company Profile

0.6.20

Cohen; Rakefet - Kokhav Ya'ir-Tzur Yigal IL
Cohen; Rakefet - Kokhave Yair - Zur Yga'al IL
Cohen; Rakefet - Zur Yigal IL
Cohen; Rakefet - Kokhav-Yair IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process For Manufacturing Glatiramer Acetate Product App 20180036363 - Cohen; Rakefet ; et al.	2018-02-08
Process For Manufacturing Glatiramer Acetate Product App 20180000884 - Cohen; Rakefet ; et al.	2018-01-04
Process For Manufacturing Glatiramer Acetate Product App 20170312331 - Cohen; Rakefet ; et al.	2017-11-02
Process for manufacturing glatiramer acetate product Grant 9,763,993 - Cohen , et al. September 19, 2	2017-09-19
Process For Manufacturing Glatiramer Acetate Product App 20170196930 - Cohen; Rakefet ; et al.	2017-07-13
Combination Formulation Of Laquinimod And Glatiramer Acetate With Amino Acids App 20170028013 - Linden; Galina ; et al.	2017-02-02
Process For Manufacturing Glatiramer Acetate Product App 20160213734 - Cohen; Rakefet ; et al.	2016-07-28
Process for manufacturing glatiramer acetate product Grant 9,155,775 - Cohen , et al. October 13, 2	2015-10-13
STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY App 20120046253 - Cohen; Rakefet ; et al.	2012-02-23
STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D-CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY App 20120028934 - COHEN; Rakefet ; et al.	2012-02-02
Chewable formulations App 20090137606 - Cohen; Rakefet	2009-05-28
Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof App 20080187584 - Cohen; Rakefet ; et al.	2008-08-07
Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof Grant 7,396,542 - Fox , et al. July 8, 2	2008-07-08
Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof Grant 7,357,945 - Cohen , et al. April 15, 2	2008-04-15
Stable pharmacologically active compositions including vitamin D-containing and corticosteroid compounds with low pH compatibility App 20080064669 - Cohen; Rakefet ; et al.	2008-03-13
Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof Grant 7,138,137 - Cohen , et al. November 21, 2	2006-11-21
Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof App 20050191350 - Fox, Michael ; et al.	2005-09-01
Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof App 20050059701 - Cohen, Rakefet ; et al.	2005-03-17
Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof App 20030158230 - Cohen, Rakefet ; et al.	2003-08-21
Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof App 20030144324 - Fox, Michael ; et al.	2003-07-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.